These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28328626)

  • 1. Central Serous Chorioretinopathy in a Patient with Ulcerative Colitis with Pouchitis on Budesonide-EC.
    Zullow S; Fazelat A; Farraye FA
    Inflamm Bowel Dis; 2017 May; 23(5):E19. PubMed ID: 28328626
    [No Abstract]   [Full Text] [Related]  

  • 2. A patient with ulcerative colitis and central serous chorioretinopathy--a therapeutic dilemma.
    Geyshis B; Katz G; Ben-Horin S; Kopylov U
    J Crohns Colitis; 2013 Mar; 7(2):e66-8. PubMed ID: 22621790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central serous chorioretinopathy in patients who cannot discontinue steroids.
    Katsanos A; Stefaniotou M
    J Crohns Colitis; 2013 Feb; 7(1):e25. PubMed ID: 22818165
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis.
    D'Haens GR; Kovács A; Vergauwe P; Nagy F; Molnár T; Bouhnik Y; Weiss W; Brunner H; Lavergne-Slove A; Binelli D; Di Stefano AF; Marteau P
    J Crohns Colitis; 2010 Jun; 4(2):153-60. PubMed ID: 21122499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Budesonide enema in pouchitis--a double-blind, double-dummy, controlled trial.
    Sambuelli A; Boerr L; Negreira S; Gil A; Camartino G; Huernos S; Kogan Z; Cabanne A; Graziano A; Peredo H; Doldán I; Gonzalez O; Sugai E; Lumi M; Bai JC
    Aliment Pharmacol Ther; 2002 Jan; 16(1):27-34. PubMed ID: 11856075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide rectal foam (Uceris) for ulcerative colitis.
    Med Lett Drugs Ther; 2015 Nov; 57(1481):154. PubMed ID: 26529134
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral budesonide in the treatment of chronic refractory pouchitis.
    Gionchetti P; Rizzello F; Poggioli G; Pierangeli F; Laureti S; Morselli C; Tambasco R; Calabrese C; Campieri M
    Aliment Pharmacol Ther; 2007 May; 25(10):1231-6. PubMed ID: 17451569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide MMX(®): a review of its use in patients with mild to moderate ulcerative colitis.
    Hoy SM
    Drugs; 2015 May; 75(8):879-86. PubMed ID: 25920500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budesonide MMX in Paediatric Patients With Ulcerative Colitis.
    Karolewska-Bochenek K; Dziekiewicz M; Banaszkiewicz A
    J Crohns Colitis; 2017 Oct; 11(11):1402. PubMed ID: 28505293
    [No Abstract]   [Full Text] [Related]  

  • 10. Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study.
    Sandborn WJ; Travis S; Moro L; Jones R; Gautille T; Bagin R; Huang M; Yeung P; Ballard ED
    Gastroenterology; 2012 Nov; 143(5):1218-1226.e2. PubMed ID: 22892337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis.
    Hartmann F; Stein J;
    Aliment Pharmacol Ther; 2010 Aug; 32(3):368-76. PubMed ID: 20491741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A safety evaluation of budesonide MMX for the treatment of ulcerative colitis.
    Bezzio C; Festa S; Zerboni G; Papi C; Manes G; Saibeni S
    Expert Opin Drug Saf; 2018 Apr; 17(4):437-444. PubMed ID: 29473429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis.
    Hammond A; Andus T; Gierend M; Ecker KW; Scholmerich J; Herfarth H;
    Hepatogastroenterology; 2004; 51(59):1345-9. PubMed ID: 15362749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of oral budesonide in the treatment of active distal ulcerative colitis.
    Kolkman JJ; Möllmann HW; Möllmann AC; Penã AS; Greinwald R; Tauschel HD; Hochhaus G
    Drugs Today (Barc); 2004 Jul; 40(7):589-601. PubMed ID: 15510233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Budesonide foam as a new therapeutic principle in distal ulcerative colitis in comparison with mesalazine enema. An open, controlled, randomized and prospective multicenter pilot study].
    Rufle W; Frühmorgen P; Huber W; Kimmig JM
    Z Gastroenterol; 2000 Apr; 38(4):287-93. PubMed ID: 10820860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats.
    Ahmadi F; Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
    Drug Deliv; 2011 Feb; 18(2):122-30. PubMed ID: 20954795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis.
    Lichtenstein GR
    Dig Dis Sci; 2016 Feb; 61(2):358-70. PubMed ID: 26541989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technology.
    Bezzio C; Fascì-Spurio F; Viganò C; Meucci G; Papi C; Saibeni S
    Expert Rev Gastroenterol Hepatol; 2017 Jan; 11(1):33-41. PubMed ID: 27805459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Steroids in inflammatory bowel disease].
    López San Román A; Garrido E
    Rev Esp Enferm Dig; 2015 Sep; 107(9):573. PubMed ID: 26334467
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic inflammatory bowel diseases].
    Herrlinger K; Stange EF
    Dtsch Med Wochenschr; 2004 Oct; 129(42):2241-50; quiz 2251-4. PubMed ID: 15529447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.